Study on the Effective Dose of Alfentanil Combined with Ciprofol in Inhibiting Intraoperative Body Movement Responses in Patients Undergoing Breast Lump Resection

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2500109829

Enrollment

Unknown

Registered

2025-09-25

Start date

2025-09-30

Completion date

Unknown

Last updated

2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast lump

Interventions

case series:Alfentanil (Modified Dixon Sequential Method) + Ciprofol

Eligibility

Sex/Gender

Female

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age: 18 - 65 years old; BMI: 18.5 - 25.0 kg/m^2; ASA classification: ?-? grade; Female patients with breast masses less than 5 cm

Exclusion criteria

Exclusion criteria: Difficult airway, patients who have been using opioid or sedative drugs for a long time before the operation, long-term alcohol drinkers, and those with allergies

Design outcomes

Primary

Measure	Time frame
body movement response;	—

Secondary

Measure	Time frame
blood pressure;heart rate;Oxygen saturation;	—

Countries

China

Contacts

Public ContactGang Lu

Suzhou Municipal Hospital

1Lu.gang@163.com+86 133 3870 0670

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026